EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Prince Pharmaceutical Co's Enterprise Value is NT$1,341.5 Mil.
Prince Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.3 Mil. Therefore, Prince Pharmaceutical Co's EV-to-FCF for today is 5,240.18.
The historical rank and industry rank for Prince Pharmaceutical Co's EV-to-FCF or its related term are showing as below:
ROCO:6935'
s EV-to-FCF Range Over the Past 10 Years
Min: 22.19 Med: 25.76 Max: 6575.98
Current: 5240.18
During the past 5 years, the highest EV-to-FCF of Prince Pharmaceutical Co was 6575.98. The lowest was 22.19. And the median was 25.76.
ROCO:6935's EV-to-FCF is ranked worse than 100% of 535
companies
in the Drug Manufacturers industry
Industry Median: 22.83
vs ROCO:6935: 5240.18
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prince Pharmaceutical Co's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Prince Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prince Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prince Pharmaceutical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Prince Pharmaceutical Co's EV-to-FCF falls into.
Prince Pharmaceutical Co's current Enterprise Value is NT$1,341.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prince Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prince Pharmaceutical Co (ROCO:6935) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Prince Pharmaceutical Co's PE Ratio for today is calculated as:
Prince Pharmaceutical Co's share price for today is NT$26.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prince Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.420.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Prince Pharmaceutical Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Prince Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Prince Pharmaceutical Co (ROCO:6935) Business Description
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:6935 has been successfully added to your